News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
736,688 Results
Type
Article (43228)
Company Profile (274)
Press Release (693174)
Multimedia
Podcasts (87)
Webinars (19)
Section
Business (208997)
Career Advice (2119)
Deals (36023)
Drug Delivery (116)
Drug Development (82526)
Employer Resources (177)
FDA (16606)
Job Trends (15179)
News (352861)
Policy (33322)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2657)
Accelerated approval (33)
Adcomms (30)
Allergies (142)
Alliances (50544)
ALS (170)
Alzheimer's disease (1688)
Antibody-drug conjugate (ADC) (317)
Approvals (16873)
Artificial intelligence (521)
Autoimmune disease (156)
Automation (39)
Bankruptcy (364)
Best Places to Work (11778)
BIOSECURE Act (20)
Biosimilars (192)
Biotechnology (175)
Bladder cancer (157)
Brain cancer (57)
Breast cancer (647)
Cancer (4849)
Cardiovascular disease (401)
Career advice (1793)
Career pathing (38)
CAR-T (286)
CDC (45)
Celiac Disease (2)
Cell therapy (757)
Cervical cancer (36)
Clinical research (70431)
Collaboration (1728)
Company closure (4)
Compensation (1162)
Complete response letters (55)
COVID-19 (2744)
CRISPR (90)
C-suite (861)
Cystic fibrosis (143)
Data (6268)
Decentralized trials (2)
Denatured (29)
Depression (132)
Diabetes (508)
Diagnostics (6821)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (258)
Drug pricing (190)
Drug shortages (28)
Duchenne muscular dystrophy (232)
Earnings (91997)
Editorial (58)
Employer branding (21)
Employer resources (155)
Events (120009)
Executive appointments (987)
FDA (19739)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1485)
Gene editing (196)
Generative AI (44)
Gene therapy (607)
GLP-1 (983)
Government (4759)
Grass and pollen (6)
Guidances (384)
Healthcare (19184)
HIV (60)
Huntington's disease (45)
IgA nephropathy (83)
Immunology and inflammation (250)
Immuno-oncology (58)
Indications (110)
Infectious disease (3018)
Inflammatory bowel disease (192)
Inflation Reduction Act (14)
Influenza (117)
Intellectual property (251)
Interviews (328)
IPO (16842)
IRA (50)
Job creations (3740)
Job search strategy (1504)
JPM (57)
Kidney cancer (16)
Labor market (86)
Layoffs (556)
Leadership (34)
Legal (8084)
Liver cancer (92)
Longevity (14)
Lung cancer (657)
Lymphoma (376)
Machine learning (42)
Management (61)
Manufacturing (803)
MASH (164)
Medical device (14016)
Medtech (14071)
Mergers & acquisitions (20259)
Metabolic disorders (1286)
Multiple sclerosis (161)
NASH (16)
Neurodegenerative disease (323)
Neuropsychiatric disorders (88)
Neuroscience (2929)
Neurotech (1)
NextGen: Class of 2026 (6632)
Non-profit (4623)
Now hiring (67)
Obesity (607)
Opinion (270)
Ovarian cancer (166)
Pain (199)
Pancreatic cancer (230)
Parkinson's disease (287)
Partnered (34)
Patents (498)
Patient recruitment (492)
Peanut (56)
People (60194)
Pharmaceutical (66)
Pharmacy benefit managers (29)
Phase 1 (21941)
Phase 2 (30975)
Phase 3 (23086)
Pipeline (5302)
Policy (285)
Postmarket research (2652)
Preclinical (9365)
Press Release (64)
Prostate cancer (241)
Psychedelics (50)
Radiopharmaceuticals (280)
Rare diseases (842)
Real estate (6104)
Recruiting (71)
Regulatory (24911)
Reports (52)
Research institute (2455)
Resumes & cover letters (361)
Rett syndrome (27)
RNA editing (16)
RSV (78)
Schizophrenia (150)
Series A (240)
Series B (190)
Service/supplier (11)
Sickle cell disease (97)
Special edition (21)
Spinal muscular atrophy (158)
Sponsored (43)
Startups (3675)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (86)
The Weekly (56)
Vaccines (1021)
Venture capital (90)
Weight loss (391)
Women's health (93)
Worklife (19)
Date
Today (29)
Last 7 days (586)
Last 30 days (2036)
Last 365 days (30085)
2026 (3485)
2025 (30473)
2024 (35528)
2023 (40487)
2022 (51678)
2021 (56305)
2020 (54768)
2019 (47460)
2018 (35744)
2017 (32833)
2016 (32304)
2015 (38445)
2014 (32136)
2013 (27117)
2012 (29402)
2011 (30038)
2010 (28132)
Location
Africa (782)
Alabama (83)
Alaska (7)
Arizona (313)
Arkansas (13)
Asia (40780)
Australia (6717)
California (11344)
Canada (3294)
China (1122)
Colorado (479)
Connecticut (480)
Delaware (337)
Europe (89093)
Florida (1692)
Georgia (356)
Hawaii (3)
Idaho (61)
Illinois (866)
India (67)
Indiana (522)
Iowa (22)
Japan (436)
Kansas (127)
Kentucky (38)
Louisiana (26)
Maine (83)
Maryland (1393)
Massachusetts (8140)
Michigan (331)
Minnesota (634)
Mississippi (5)
Missouri (137)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (79)
New Jersey (3011)
New Mexico (28)
New York (2989)
North Carolina (1489)
North Dakota (8)
Northern California (5529)
Ohio (337)
Oklahoma (22)
Oregon (41)
Pennsylvania (2283)
Puerto Rico (24)
Rhode Island (48)
South America (1156)
South Carolina (66)
South Dakota (1)
Southern California (4424)
Tennessee (174)
Texas (1758)
United States (40283)
Utah (337)
Vermont (1)
Virginia (261)
Washington D.C. (83)
Washington State (921)
West Virginia (4)
Wisconsin (115)
Wyoming (2)
736,688 Results for "baxter international inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Baxter to Host Fourth-Quarter 2025 Financial Results Conference Call for Investors
January 22, 2026
·
1 min read
Press Releases
Baxter Reports Third-Quarter 2025 Results
October 31, 2025
·
20 min read
Policy
Exergen Sues Baxter International to Defend Its Right to Publish Data Regarding the Accuracy of Oral Thermometers
Last week Exergen Corporation filed a lawsuit against Baxter International Inc. in the United States District Court for the District of Massachusetts.
April 24, 2024
·
1 min read
Press Releases
Baxter Reports Second-Quarter 2025 Results
July 31, 2025
·
20 min read
Business
Baxter Reports First-Quarter 2024 Results
Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2024.
May 2, 2024
·
31 min read
Press Releases
Oncotelic Therapeutics, Inc. and Sapu Bioscience Expand International IP Coverage for OT-101, Strengthening CNS and Neurology Commercialization Pathway
February 12, 2026
·
6 min read
Press Releases
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)
January 15, 2026
·
6 min read
Deals
Baxter Declares Quarterly Dividend - May 7, 2024
Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock.
May 7, 2024
·
1 min read
Deals
Advent International and Warburg Pincus Complete Acquisition of Baxter’s BioPharma Solutions Business
Advent International, one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor, announced the completion of their previously announced acquisition of Baxter International Inc.’s BioPharma Solutions business.
October 2, 2023
·
4 min read
BioMidwest
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.
Baxter International Inc. announced the continued expansion of its Pharmaceuticals portfolio with five injectable product launches in the U.S. “These launches demonstrate Baxter’s focus on differentiated products that address unmet patient needs in key therapeutic areas, including anti-infective and anti-hypotensive medications,” said Alok Sonig, executive vice president and group president, Pharmaceuticals, at Baxter.
April 11, 2024
·
19 min read
1 of 73,669
Next
